A 0 1 0 1 O
urine 2 7 2 7 O
pregnancy 8 17 8 17 B-pregnancy
test 18 22 18 22 O
will 23 27 23 27 O
be 28 30 28 30 O
performed 31 40 31 40 O
within 41 47 41 47 O
48 48 50 48 50 B-upper_bound
hours 51 56 51 56 I-upper_bound
before 57 63 57 63 O
the 64 67 64 67 O
RNA 68 71 68 71 B-treatment
CART19 72 78 72 78 I-treatment
infusion 79 87 79 87 O

ALT 0 3 88 91 B-clinical_variable
< 4 5 92 93 O
5 6 7 94 95 B-upper_bound
times 8 13 96 101 I-upper_bound
the 14 17 102 105 I-upper_bound
ULN 18 21 106 109 I-upper_bound
for 22 25 110 113 O
age 26 29 114 117 B-age

Active 0 6 118 124 B-chronic_disease
hepatitis 7 16 125 134 I-chronic_disease
B 17 18 135 136 I-chronic_disease

Anti 0 4 137 141 B-treatment
- 4 5 141 142 I-treatment
CD20 5 9 142 146 I-treatment
monoclonal 10 20 147 157 I-treatment
antibody 21 29 158 166 I-treatment
therapy 30 37 167 174 I-treatment
within 38 44 175 181 O
the 45 48 182 185 O
last 49 53 186 190 B-upper_bound
3 54 55 191 192 I-upper_bound
months 56 62 193 199 I-upper_bound
, 62 63 199 200 O
or 64 66 201 203 O
absence 67 74 204 211 O
of 75 77 212 214 O
circulating 78 89 215 226 O
B 90 91 227 228 O
cells 92 97 229 234 O

Are 0 3 235 238 O
more 4 8 239 243 O
than 9 13 244 248 O
6 14 15 249 250 B-lower_bound
months 16 22 251 257 I-lower_bound
from 23 27 258 262 O
transplant 28 38 263 273 B-treatment
6 39 40 274 275 I-treatment
) 40 41 275 276 O
Karnofsky 42 51 277 286 B-clinical_variable
performance 52 63 287 298 I-clinical_variable
status 64 70 299 305 I-clinical_variable
≥ 71 72 306 307 O
50 73 75 308 310 B-lower_bound
at 76 78 311 313 O
screening 79 88 314 323 O

Creatinine 0 10 324 334 B-clinical_variable
clearance 11 20 335 344 I-clinical_variable
or 21 23 345 347 O
radioisotope 24 36 348 360 B-clinical_variable
GFR 37 40 361 364 I-clinical_variable
> 41 42 365 366 O
60 43 45 367 369 B-lower_bound
mL 46 48 370 372 I-lower_bound
/ 48 49 372 373 I-lower_bound
min/1.73 49 57 373 381 I-lower_bound
m2 58 60 382 384 I-lower_bound

HL 0 2 385 387 B-chronic_disease
with 3 7 388 392 O
biopsy 8 14 393 399 O
- 14 15 399 400 O
proven 15 21 400 406 O
relapse 22 29 407 414 O

Have 0 4 415 419 O
no 5 7 420 422 O
active 8 14 423 429 B-chronic_disease
GVHD 15 19 430 434 I-chronic_disease

History 0 7 435 442 O
of 8 10 443 445 O
allergy 11 18 446 453 O
or 19 21 454 456 O
hypersensitivity 22 38 457 473 O
to 39 41 474 476 O
study 42 47 477 482 O
product 48 55 483 490 O
excipients 56 66 491 501 O
( 67 68 502 503 O
human 68 73 503 508 B-allergy_name
serum 74 79 509 514 I-allergy_name
albumin 80 87 515 522 I-allergy_name
, 87 88 522 523 O
DMSO 89 93 524 528 B-allergy_name
, 93 94 528 529 O
and 95 98 530 533 O
Dextran 99 106 534 541 B-allergy_name
40 107 109 542 544 I-allergy_name
) 109 110 544 545 O

History 0 7 546 553 O
of 8 10 554 556 O
allergy 11 18 557 564 O
to 19 21 565 567 O
murine 22 28 568 574 B-allergy_name
proteins 29 37 575 583 I-allergy_name

Left 0 4 584 588 B-clinical_variable
Ventricular 5 16 589 600 I-clinical_variable
Ejection 17 25 601 609 I-clinical_variable
Fraction 26 34 610 618 I-clinical_variable
( 35 36 619 620 I-clinical_variable
LVEF 36 40 620 624 I-clinical_variable
) 40 41 624 625 I-clinical_variable
> 42 43 626 627 O
45 44 46 628 630 B-lower_bound
% 46 47 630 631 I-lower_bound
confirmed 48 57 632 641 O
by 58 60 642 644 O
echocardiogram 61 75 645 659 O
or 76 78 660 662 O
MUGA 79 83 663 667 O

Left 0 4 668 672 B-clinical_variable
Ventricular 5 16 673 684 I-clinical_variable
Shortening 17 27 685 695 I-clinical_variable
Fraction 28 36 696 704 I-clinical_variable
( 37 38 705 706 I-clinical_variable
LVSF 38 42 706 710 I-clinical_variable
) 42 43 710 711 I-clinical_variable
> 44 45 712 713 O
28 46 48 714 716 B-lower_bound
% 48 49 716 717 I-lower_bound
confirmed 50 59 718 727 O
by 60 62 728 730 O
echocardiogram 63 77 731 745 O

Male 0 4 746 750 B-gender

Must 0 4 751 755 O
have 5 9 756 760 O
a 10 11 761 762 O
minimum 12 19 763 770 O
level 20 25 771 776 B-clinical_variable
of 26 28 777 779 I-clinical_variable
pulmonary 29 38 780 789 I-clinical_variable
reserve 39 46 790 797 I-clinical_variable
defined 47 54 798 805 O
as 55 57 806 808 O
≤ 58 59 809 810 O
Grade 60 65 811 816 B-upper_bound
1 66 67 817 818 I-upper_bound
dyspnea 68 75 819 826 O
and 76 79 827 830 O
pulse 80 85 831 836 B-chronic_disease
oxygenation 86 97 837 848 I-chronic_disease
> 98 99 849 850 O
94 100 102 851 853 B-lower_bound
% 102 103 853 854 I-lower_bound
on 104 106 855 857 O
room 107 111 858 862 O
air 112 115 863 866 O

Patients 0 8 867 875 O
ages 9 13 876 880 B-age
22 14 16 881 883 B-lower_bound
- 16 17 883 884 O
24 17 19 884 886 B-upper_bound

Patients 0 8 887 895 O
with 9 13 896 900 O
known 14 19 901 906 O
active 20 26 907 913 O
CNS 27 30 914 917 B-cancer
involvement 31 42 918 929 I-cancer
by 43 45 930 932 I-cancer
malignancy 46 56 933 943 I-cancer

Patients 0 8 944 952 O
with 9 13 953 957 O
prior 14 19 958 963 O
CNS 20 23 964 967 B-chronic_disease
disease 24 31 968 975 I-chronic_disease
that 32 36 976 980 O
has 37 40 981 984 O
been 41 45 985 989 O
effectively 46 57 990 1001 O
treated 58 65 1002 1009 O
will 66 70 1010 1014 O
be 71 73 1015 1017 O
eligible 74 82 1018 1026 O
providing 83 92 1027 1036 O
treatment 93 102 1037 1046 O
was 103 106 1047 1050 O
> 107 108 1051 1052 O
4 108 109 1052 1053 B-lower_bound
weeks 110 115 1054 1059 I-lower_bound
before 116 122 1060 1066 O
enrollment 123 133 1067 1077 O

Serum 0 5 1078 1083 B-clinical_variable
creatinine 6 16 1084 1094 I-clinical_variable
: 16 17 1094 1095 O
< 18 19 1096 1097 O
1.7mg 20 25 1098 1103 B-upper_bound
/ 25 26 1103 1104 I-upper_bound
dL 26 28 1104 1106 I-upper_bound
( 29 30 1107 1108 O
male 30 34 1108 1112 B-gender
subjects 35 43 1113 1121 I-gender
) 43 44 1121 1122 O
or 45 47 1123 1125 O
< 48 49 1126 1127 O
1.4mg 50 55 1128 1133 B-upper_bound
/ 55 56 1133 1134 I-upper_bound
dL 56 58 1134 1136 I-upper_bound
( 59 60 1137 1138 O
female 60 66 1138 1144 B-gender
subjects 67 75 1145 1153 I-gender
) 75 76 1153 1154 O

Total 0 5 1155 1160 B-clinical_variable
Bilirubin 6 15 1161 1170 I-clinical_variable
< 16 17 1171 1172 O
2.0 18 21 1173 1176 B-upper_bound
mg 22 24 1177 1179 I-upper_bound
/ 24 25 1179 1180 I-upper_bound
dl 25 27 1180 1182 I-upper_bound

Uncontrolled 0 12 1183 1195 O
active 13 19 1196 1202 B-chronic_disease
infection 20 29 1203 1212 I-chronic_disease

Unstable 0 8 1213 1221 B-chronic_disease
angina 9 15 1222 1228 I-chronic_disease
and/or 16 22 1229 1235 O
myocardial 23 33 1236 1246 B-chronic_disease
infarction 34 44 1247 1257 I-chronic_disease
within 45 51 1258 1264 O
6 52 53 1265 1266 B-upper_bound
months 54 60 1267 1273 I-upper_bound
prior 61 66 1274 1279 I-upper_bound
to 67 69 1280 1282 O
screening 70 79 1283 1292 O

female 0 6 1293 1299 B-gender

have 0 4 1300 1304 O
a 5 6 1305 1306 O
limited 7 14 1307 1314 O
prognosis 15 24 1315 1324 O
( 25 26 1325 1326 O
several 26 33 1326 1333 O
months 34 40 1334 1340 O
to 41 43 1341 1343 O
< 44 45 1344 1345 O
2 46 47 1346 1347 B-upper_bound
year 48 52 1348 1352 I-upper_bound
survival 53 61 1353 1361 O
) 61 62 1361 1362 O
with 63 67 1363 1367 O
currently 68 77 1368 1377 O
available 78 87 1378 1387 O
therapies 88 97 1388 1397 O
will 98 102 1398 1402 O
be 103 105 1403 1405 O
enrolled 106 114 1406 1414 O

refractory 0 10 1415 1425 B-chronic_disease
disease 11 18 1426 1433 I-chronic_disease
who 19 22 1434 1437 O
are 23 26 1438 1441 O
unresponsive 27 39 1442 1454 O
to 40 42 1455 1457 O

require 0 7 1458 1465 O
no 8 10 1466 1468 O
immunosuppression 11 28 1469 1486 B-treatment

subjects 0 8 1487 1495 O
with 9 13 1496 1500 O
HL 14 16 1501 1503 B-chronic_disease
with 17 21 1504 1508 O
no 22 24 1509 1511 O
available 25 34 1512 1521 O
curative 35 43 1522 1530 B-treatment
treatment 44 53 1531 1540 I-treatment
options 54 61 1541 1548 O
( 62 63 1549 1550 O
such 63 67 1550 1554 O
as 68 70 1555 1557 O
autologous 71 81 1558 1568 B-treatment
SCT 82 85 1569 1572 I-treatment
) 85 86 1572 1573 O

